Neratinib Recruiting Phase 1 / 2 Trials for Malignant Lymphomas / Tumors, Solid / Tumors, Central Nervous System / Leukemias Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs